Summary
Free and bound fractions of salicylates were separated by equilibrium dialysis and measured by spectrofluorimetry in 27 patients with rheumatoid arthritis and in 16 controls. The results showed that in patients with rheumatoid arthritis, the binding of salicylate to proteins decreased in an overproportional manner with the decrease of serum albumin concentrations. This phenomenon was linked with the severity of the inflammatory syndrome. The saturation binding capacity per unit of protein concentration was lower in the patients suffering from active forms of the condition, a finding which suggests that the changes observed are not due only to quantita-tive changes in the serum albumins.
This study confirms the importance of determining free salicylate concentrations in the treatment of patients with inflammatory diseases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Tillement J.P., Lhoste F., Giudicelli J.F. (1978): Diseases and drug protein binding. Clinical Pharmacokinetics,3, 144–154.
Mc Arthur J.N., Smith M.J.H. (1969): The determination of the binding of salicylate to serum proteins. J. Pharm. Pharmacol.,21, 589–594.
Scatchard G. (1949): The attraction of proteins for small molecules and ions. Ann. NY Acad. Sci.,51, 660–672.
Vallner J.J., Perrin J.H., Wold S. (1976): Comparison of graphical and computerized methods for calculating binding parameters for two strongly bound drugs. J. Pharm. Sci.,8, 1182–1187.
Perrin J.H., Vallner J., Wold S. (1974): An unbiased method for estimating binding parameters in a noncooperative binding process. Biochem. Biophys. Acta,371, 482–490.
Monot C, Netter P., Stalars M.C., Martin J., Royer R.J., Gaucher A. (1983): Difficulties in applying the Scatchard model of ligand binding to proteins. Proposal of new mathematical tools. Application to salicylates. J. Pharm. Sci.,72, 35–41.
Behm H.L., Wagner J.G. (1981): Parabolic equation relating free and total drug concentrations in cases of non linear plasma protein binding. J. Pharm. Sci.,70, 802–804.
Monot C. (1975) : Identification des paramètres d’un système intégro-différentiel. Application au problème biologique de la cinétique pathologique du fer radioactif. Thèse de Doctorat es-Sciences, Nancy.
Reynolds R.C., Cluff L.E. (1960): Interaction of serum and sodium salicylate: changes during acute infection and its influence on pharmacological activity. Bull. Johns Hopkins Hosp.,107, 278–290.
Levy G. (1978): Clinical pharmacokinetics of aspirin. Pediatrics,62, 867–872.
Wallace S., Whitting B., Runcie J. (1976): Factors affecting drug binding in plasma of elderly patients. Br. J. Clin. Pharmacol.,3, 327–330.
Windorfer A., Karitzky D., Gasteiger U., Stehr K. (1978): Investigations on salicylate protein binding in newborns and infants. Eur. J. Pediat.,127, 163–172.
Borga O., Odar-Cederlof J., Ringberger V.A., Norlin A. (1976): Protein binding of salicylate in uremic and normal plasma. Clin. Pharmacol. Ther.,20, 464–475.
Perez-Mateo M., Erill S. (1977): Protein of salicylate and quinidine in plasma from patients with renal failure, chronic liver disease and chronic respiratory insufficiency. Europ. J. Clin. Pharmacol.,11, 225–231.
Wallace S., Brodie M.J. (1976): Decreased drug binding in serum from patients with chronic hepatic disease. Europ. J. Clin. Pharmacol.,9, 429–432.
Cockel R., Kendall M.J., Becker J.F., Hawkins C.F. (1971): Serum biochemical values in rheumatoid disease. Ann. Rheum. Dis.,30, 166–170.
Wosilait W.D. (1976): Theoretical analysis of the binding of salicylate by human serum albumin: the relationship between free and bound drug and therapeutic levels. Europ. J. Clin. Pharmacol.,9, 285–290.
Zarolinski J.F., Keresztes-Nagy S., Mais R.F., Oesler Y. (1974): Effect of temperature on the binding of salicylate by human serum albumin. Biochem. pharmacol.,23, 1767–1776.
Dromgoole S.H., Furst DE: Salicylates in W.E. Evans, J.J. Schentag, W.J. Jusko (Ed.) (1980), Applied pharmacokinetics. Applied therapeutics Inc. San Francisco, pp. 486–517.
Ekstrand R., Alvan G., Borga O. (1979): Concentration dependent plasma protein binding of salicylate in rheumatoid patients. Clinical pharmacokinetics,4, 137–143.
Pachman L.M., Olufs R., Procknal J.A., Levy G. (1979): Pharmacokinetic monitoring of salicylate therapy in children with juvenile rheumatoid arthritis. Arthritis. Rheum.,22, 826–831.
Poe T.E., Mutchie K.D., Sauders G.H., Hanissian A.S., Sotello C.A. (1980): Total and free salicylate concentations in juvenile rheumatoid arthritis. Journal of rheumatology,7, 717–723.
Trnavska Z., Trnavsky K. (1980): Characterization of salicylate binding to synovial fluid and plasma protein in patients with rheumatoid arthritis. Europ. J. Clin. Pharmacol.,18, 403–406.
Wanwimolruk S., Birkett D.J., Brooks P.M. (1982): Protein binding of some non-stéroidal anti-inflammatory drugs in rheumatoid arthritis. Clinical pharmacokinetics,7, 85–92.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Netter, P., Monot, C., Stalars, M.C. et al. Decrease of in vitro serum protein binding of salicylate in rheumatoid arthritis. European Journal of Drug Metabolism and Pharmacokinetics 9, 109–116 (1984). https://doi.org/10.1007/BF03189613
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189613